T1	Concept 10 16	RNAseq
T2	Action 17 27	identified
T3	Concept 31 42	RNA viruses
R1	subject Arg1:T2 Arg2:T1	
R2	target Arg1:T2 Arg2:T3	
T4	Concept 28 30	10
R3	in-context Arg1:T3 Arg2:T4	
T5	Action 57 73	have established
R4	in-context Arg1:T5 Arg2:T3	
T6	Concept 74 87	pathogenicity
R5	target Arg1:T5 Arg2:T6	
T7	Concept 95 100	lungs
R6	in-place Arg1:T6 Arg2:T7	
T8	Concept 110 127	RNA intermediates
R7	target Arg1:T5 Arg2:T8	
T9	Concept 136 147	DNA viruses
T10	Concept 131 135	five
R8	in-context Arg1:T9 Arg2:T10	
T11	Concept 168 191	pulmonary pathogenicity
R9	has-property Arg1:T9 Arg2:T11	
A1	Uncertain T11
T12	Concept 192 198	DNAseq
T13	Action 199 209	identified
R10	subject Arg1:T13 Arg2:T12	
T14	Concept 214 221	genomes
R11	target Arg1:T13 Arg2:T14	
T15	Concept 241 252	DNA viruses
T16	Concept 236 240	five
T17	Reference 225 235	these same
R12	in-context Arg1:T15 Arg2:T16	
R13	in-context Arg1:T16 Arg2:T17	
T18	Concept 269 275	others
T19	Concept 264 268	five
R14	in-context Arg1:T19 Arg2:T17	
R15	in-context Arg1:T18 Arg2:T19	
T20	Action 276 285	including
T21	Concept 286 289	CMV
T22	Concept 294 299	HHV-6
T24	Concept 333 344	pneumonitis
R19	subject Arg1:T20 Arg2:T18	
R20	target Arg1:T20 Arg2:T21	
R21	target Arg1:T20 Arg2:T22	
T23	Action 307 327	have been associated
R16	subject Arg1:T23 Arg2:T22	
R17	subject Arg1:T23 Arg2:T21	
R18	target Arg1:T23 Arg2:T24	
T25	Action 348 353	found
T26	Concept 345 347	We
R22	subject Arg1:T25 Arg2:T26	
T27	Concept 378 388	expression
T28	Concept 368 377	increased
A2	Emphasized T28
R23	has-property Arg1:T27 Arg2:T28	
R24	target Arg1:T25 Arg2:T27	
T29	Concept 392 400	patients
R25	in-place Arg1:T27 Arg2:T29	
T30	Concept 416 430	LRTI pathogens
R26	has-property Arg1:T29 Arg2:T30	
T31	Concept 438 443	those
R27	in-context Arg1:T31 Arg2:T29	
T32	Concept 444 451	without
R28	has-property Arg1:T31 Arg2:T32	
R29	in-context Arg1:T32 Arg2:T30	
T33	Concept 762 764	We
